• Home
• ca 27
• Cancer Antigen 27.29 Test: Uses, Procedure, Results

Cancer Antigen 27.29 Test: Uses, Procedure, Results

4.6 (690) · $ 15.50 · In stock

Cancer antigen 27.29 (CA 27.29) is a blood test that monitors metastatic breast cancer. Although valuable, it has limitations in what it can detect.

Tumor Marker - an overview

Receipt of Other Procedures From 3 to 24 Months After Diagnosis

Prevalence of CA 27.29 in primary breast cancer patients before

Table 4 from Serum tumor markers.

Frontiers AKR1B10 as a Potential Novel Serum Biomarker for

Specially designed for no preparation use with AIA analyzers

Tosoh Bioscience AIA-PACK™ Test Cups — Breast Cancer Marker 27.29

Frontiers Clinical validation of the novel CLIA-CA-62 assay

Cancer Antigen 27.29 Test: Uses, Procedure, Results

Frontiers Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection